Safety and efficacy of ripasudil in Japanese patients with glaucoma or ocular hypertension: 12-month interim analysis of ROCK-J, a post-marketing surveillance study

BACKGROUND: Ripasudil is approved in Japan for glaucoma or ocular hypertension (OH) when other treatments are ineffective or cannot be administered. Its long-term safety and efficacy are being examined in a post-marketing surveillance study; 12-month data are described here. METHODS: This prospectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanihara, Hidenobu, Kakuda, Takahiko, Sano, Tetsuro, Kanno, Takashi, Gunji, Ryoji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350764/
https://www.ncbi.nlm.nih.gov/pubmed/32646383
http://dx.doi.org/10.1186/s12886-020-01490-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350764/
https://www.ncbi.nlm.nih.gov/pubmed/32646383
http://dx.doi.org/10.1186/s12886-020-01490-1

Ejemplares similares